Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 0.38
CMN's Cash to Debt is ranked higher than
57% of the 310 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.33 vs. CMN: 0.38 )
CMN' s 10-Year Cash to Debt Range
Min: 0.04   Max: No Debt
Current: 0.38

Equity to Asset 0.71
CMN's Equity to Asset is ranked higher than
80% of the 304 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.60 vs. CMN: 0.71 )
CMN' s 10-Year Equity to Asset Range
Min: 0.37   Max: 0.81
Current: 0.71

0.37
0.81
Interest Coverage 21.83
CMN's Interest Coverage is ranked higher than
69% of the 210 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 25.28 vs. CMN: 21.83 )
CMN' s 10-Year Interest Coverage Range
Min: 1.4   Max: 9999.99
Current: 21.83

1.4
9999.99
F-Score: 8
Z-Score: 8.28
M-Score: -2.41
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 9/10

vs
industry
vs
history
Operating margin (%) 14.74
CMN's Operating margin (%) is ranked higher than
83% of the 306 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 11.14 vs. CMN: 14.74 )
CMN' s 10-Year Operating margin (%) Range
Min: 2.05   Max: 14.87
Current: 14.74

2.05
14.87
Net-margin (%) 9.07
CMN's Net-margin (%) is ranked higher than
80% of the 306 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.12 vs. CMN: 9.07 )
CMN' s 10-Year Net-margin (%) Range
Min: -2.35   Max: 12.33
Current: 9.07

-2.35
12.33
ROE (%) 12.91
CMN's ROE (%) is ranked higher than
85% of the 303 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.11 vs. CMN: 12.91 )
CMN' s 10-Year ROE (%) Range
Min: 5.06   Max: 22.36
Current: 12.91

5.06
22.36
ROA (%) 8.73
CMN's ROA (%) is ranked higher than
86% of the 311 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.67 vs. CMN: 8.73 )
CMN' s 10-Year ROA (%) Range
Min: 2.4   Max: 15.4
Current: 8.73

2.4
15.4
ROC (Joel Greenblatt) (%) 57.84
CMN's ROC (Joel Greenblatt) (%) is ranked higher than
92% of the 309 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 22.82 vs. CMN: 57.84 )
CMN' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 18.58   Max: 58.65
Current: 57.84

18.58
58.65
Revenue Growth (%) 13.00
CMN's Revenue Growth (%) is ranked higher than
89% of the 282 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.00 vs. CMN: 13.00 )
CMN' s 10-Year Revenue Growth (%) Range
Min: -0.6   Max: 29.4
Current: 13

-0.6
29.4
EBITDA Growth (%) 19.40
CMN's EBITDA Growth (%) is ranked higher than
89% of the 233 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.10 vs. CMN: 19.40 )
CMN' s 10-Year EBITDA Growth (%) Range
Min: 1.2   Max: 40.8
Current: 19.4

1.2
40.8
EPS Growth (%) 22.30
CMN's EPS Growth (%) is ranked higher than
87% of the 239 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.10 vs. CMN: 22.30 )
CMN' s 10-Year EPS Growth (%) Range
Min: -6.3   Max: 46.5
Current: 22.3

-6.3
46.5
» CMN's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2013

CMN Guru Trades in Q3 2013

Mario Gabelli 428,359 sh (+1.31%)
Chuck Royce 102,438 sh (-4.3%)
Jim Simons 10,950 sh (-39.67%)
» More
Q4 2013

CMN Guru Trades in Q4 2013

Steven Cohen 11,157 sh (New)
Paul Tudor Jones 10,600 sh (New)
Jim Simons 43,350 sh (+295.89%)
Mario Gabelli 424,009 sh (-1.02%)
Chuck Royce 90,338 sh (-11.81%)
» More
Q1 2014

CMN Guru Trades in Q1 2014

RS Investment Management 4,606 sh (New)
Jim Simons 67,550 sh (+55.82%)
Paul Tudor Jones Sold Out
Steven Cohen Sold Out
Mario Gabelli 415,509 sh (-2%)
Chuck Royce 72,438 sh (-19.81%)
» More
Q2 2014

CMN Guru Trades in Q2 2014

Joel Greenblatt 21,913 sh (New)
RS Investment Management 6,306 sh (+36.91%)
Mario Gabelli 395,973 sh (-4.7%)
Chuck Royce 58,438 sh (-19.33%)
Jim Simons 45,450 sh (-32.72%)
» More
» Details

Insider Trades

Latest Guru Trades with CMN

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2014-06-30 New Buy0.01%$30.52 - $36.79 $ 34.973%21913
Joel Greenblatt 2013-06-30 Sold Out 0.02%$19.533 - $23.5 $ 34.9762%0
Mario Gabelli 2013-06-30 Reduce -33.57%0.02%$19.533 - $23.5 $ 34.9762%281891
Joel Greenblatt 2013-03-31 Reduce -26.39%0.01%$12.85 - $14.59 $ 34.97152%11679
Joel Greenblatt 2012-12-31 New Buy0.03%$10.93 - $13.33 $ 34.97190%15865
Mario Gabelli 2012-06-30 Add 25.22%0.01%$9.29 - $12.08 $ 34.97236%274292
Mario Gabelli 2012-03-31 Add 63.41%0.02%$8.17 - $11.35 $ 34.97293%219042
John Keeley 2012-03-31 Sold Out 0.01%$8.17 - $11.35 $ 34.97293%0
Mario Gabelli 2011-09-30 Add 23.19%$5.89 - $8.38 $ 34.97390%85000
Mario Gabelli 2011-06-30 Add 68.29%0.01%$6.67 - $8.26 $ 34.97369%69000
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 33.60
CMN's P/E(ttm) is ranked higher than
75% of the 323 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 34.10 vs. CMN: 33.60 )
CMN' s 10-Year P/E(ttm) Range
Min: 9.24   Max: 37.66
Current: 33.6

9.24
37.66
P/B 4.08
CMN's P/B is ranked higher than
64% of the 323 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.06 vs. CMN: 4.08 )
CMN' s 10-Year P/B Range
Min: 0.77   Max: 4.67
Current: 4.08

0.77
4.67
P/S 3.03
CMN's P/S is ranked higher than
72% of the 323 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.93 vs. CMN: 3.03 )
CMN' s 10-Year P/S Range
Min: 0.51   Max: 3.43
Current: 3.03

0.51
3.43
PFCF 30.41
CMN's PFCF is ranked higher than
85% of the 323 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 220.16 vs. CMN: 30.41 )
CMN' s 10-Year PFCF Range
Min: 7.31   Max: 809.8
Current: 30.41

7.31
809.8
EV-to-EBIT 21.41
CMN's EV-to-EBIT is ranked higher than
77% of the 323 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.48 vs. CMN: 21.41 )
CMN' s 10-Year EV-to-EBIT Range
Min: 7.3   Max: 34.9
Current: 21.41

7.3
34.9
PEG 1.86
CMN's PEG is ranked higher than
93% of the 323 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. CMN: 1.86 )
CMN' s 10-Year PEG Range
Min: 0.47   Max: 7.92
Current: 1.86

0.47
7.92
Shiller P/E 49.36
CMN's Shiller P/E is ranked higher than
81% of the 323 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. CMN: 49.36 )
CMN' s 10-Year Shiller P/E Range
Min: 8.99   Max: 59.24
Current: 49.36

8.99
59.24
Current Ratio 3.03
CMN's Current Ratio is ranked higher than
77% of the 305 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.75 vs. CMN: 3.03 )
CMN' s 10-Year Current Ratio Range
Min: 1.45   Max: 5.07
Current: 3.03

1.45
5.07
Quick Ratio 1.90
CMN's Quick Ratio is ranked higher than
73% of the 305 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.82 vs. CMN: 1.90 )
CMN' s 10-Year Quick Ratio Range
Min: 0.88   Max: 2.41
Current: 1.9

0.88
2.41

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.26
CMN's Dividend Yield is ranked lower than
89% of the 177 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.36 vs. CMN: 0.26 )
CMN' s 10-Year Dividend Yield Range
Min: 0.23   Max: 0.7
Current: 0.26

0.23
0.7
Dividend Payout 0.08
CMN's Dividend Payout is ranked higher than
98% of the 323 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. CMN: 0.08 )
CMN' s 10-Year Dividend Payout Range
Min: 0.13   Max: 0.22
Current: 0.08

0.13
0.22
Dividend growth (3y) 18.90
CMN's Dividend growth (3y) is ranked higher than
92% of the 120 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.60 vs. CMN: 18.90 )
CMN' s 10-Year Dividend growth (3y) Range
Min: 0   Max: 18.9
Current: 18.9

0
18.9
Yield on cost (5-Year) 0.30
CMN's Yield on cost (5-Year) is ranked lower than
84% of the 179 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.41 vs. CMN: 0.30 )
CMN' s 10-Year Yield on cost (5-Year) Range
Min: 0.23   Max: 0.7
Current: 0.3

0.23
0.7
Share Buyback Rate -2.50
CMN's Share Buyback Rate is ranked higher than
75% of the 239 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -2.50 vs. CMN: -2.50 )
CMN' s 10-Year Share Buyback Rate Range
Min: -0.5   Max: -13.3
Current: -2.5

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 23.48
CMN's Price/Tangible Book is ranked higher than
59% of the 323 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.90 vs. CMN: 23.48 )
CMN' s 10-Year Price/Tangible Book Range
Min: 1.58   Max: 71.15
Current: 23.48

1.58
71.15
Price/DCF (Projected) 1.83
CMN's Price/DCF (Projected) is ranked higher than
83% of the 323 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.40 vs. CMN: 1.83 )
CMN' s 10-Year Price/DCF (Projected) Range
Min: 0.59   Max: 4.02
Current: 1.83

0.59
4.02
Price/Median PS Value 2.25
CMN's Price/Median PS Value is ranked higher than
55% of the 323 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.13 vs. CMN: 2.25 )
CMN' s 10-Year Price/Median PS Value Range
Min: 0.31   Max: 2.38
Current: 2.25

0.31
2.38
Price/Peter Lynch Fair Value 1.83
CMN's Price/Peter Lynch Fair Value is ranked higher than
93% of the 323 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. CMN: 1.83 )
CMN' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.49   Max: 7.59
Current: 1.83

0.49
7.59
Price/Graham Number 5.94
CMN's Price/Graham Number is ranked higher than
73% of the 323 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.33 vs. CMN: 5.94 )
CMN' s 10-Year Price/Graham Number Range
Min: 0.92   Max: 9.15
Current: 5.94

0.92
9.15
Earnings Yield (Greenblatt) 4.70
CMN's Earnings Yield (Greenblatt) is ranked higher than
68% of the 262 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.30 vs. CMN: 4.70 )
CMN' s 10-Year Earnings Yield (Greenblatt) Range
Min: 2.9   Max: 13.7
Current: 4.7

2.9
13.7
Forward Rate of Return (Yacktman) 20.18
CMN's Forward Rate of Return (Yacktman) is ranked higher than
94% of the 265 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.25 vs. CMN: 20.18 )
CMN' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 10.6   Max: 37.1
Current: 20.18

10.6
37.1

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Traded in other countries:CI2.Germany
Cantel Medical Corp was incorporated in Delaware. The Company is a provider of infection prevention and control products in the healthcare market. It specializes in the following operating segments: Water Purification and Filtration: Water purification equipment and services, filtration and separation products, and disinfectants for the medical, pharmaceutical, biotech, beverage and commercial industrial markets; Healthcare Disposables: Single-use, infection prevention and control products used principally in the dental market including face masks, sterilization pouches, towels and bibs, tray covers, saliva ejectors, germicidal wipes, plastic cups and disinfectants; Endoscope Reprocessing: Medical device reprocessing systems, disinfectants, enzymatic detergents and other supplies used to high-level disinfect flexible endoscopes; Dialysis: Medical device reprocessing systems, sterilants/disinfectants, dialysate concentrates and other supplies for renal dialysis; Therapeutic Filtration: Hollow fiber membrane filtration and separation technologies for medical applications; Specialty Packaging: Specialty packaging and thermal control products, as well as related compliance training, for the transport of infectious and biological specimens and thermally sensitive pharmaceutical, medical and other products; and Sterilants, disinfectants, detergents and decontamination services used in various applications for infection prevention and control. The Company also offers pretreatment equipment, lab water equipment, a full range of service deionization tanks and specific equipment designed to support the life sciences and industrial markets including peripheral equipment such as carts, bicarbonate and acid delivery systems with central and single mix distribution units, and concentrate systems with central concentrate holding tanks. It provides service and maintenance for water purification systems in the United States and Canada through eighteen regional offices. The Company offers a full line of filters utilizing hollow fiber membrane technology. The filters are sold under the names of FiberFlo(r) Capsule Filters and FiberFlo Cartridge Filters. Other products include microfiber and flat sheet membrane prefiltration products. FiberFlo filter products are sold directly and through various s third-party distributors in the United States, Puerto Rico, Canada and other international markets. Its dialyzer reprocessing products include the Renatron II Automated Dialyzer Reprocessing System (Renatron System), the Renalog RM Data Management System and Renalin Cold 100 Sterilant, a peracetic acid based sterilant. Its renal dialysis treatment products include a line of acid and bicarbonate concentrates, referred to as dialysate concentrates. The Company's Medivators product portfolio represents the offerings of capital equipment, chemistries, consumables and services that are used to pre-clean, leak test, clean and disinfect flexible endoscopes. Its
» More Articles for CMN

Headlines

Articles On GuruFocus.com
Small items not cut Mar 03 2013 
Cantel Medical Corp. (CMN) Sr. V.P., CFO and Treasurer Craig A Sheldon sells 2,607 Shares Mar 15 2011 
Cantel Medical Corp. Reports Operating Results (10-Q) Mar 11 2011 
Cantel Medical Corp. Reports Operating Results (10-Q) Dec 10 2010 
Cantel Medical Corp. Reports Operating Results (10-K) Oct 14 2010 
Cantel Medical Corp. Reports Operating Results (10-Q) Jun 09 2010 
Cantel Medical Corp. (CMN) President and CEO Andrew A Krakauer sells 11,505 Shares Apr 09 2010 
Cantel Medical Corp. (CMN) Chairman, 10% Owner Charles M Diker buys 5,000 Shares Oct 26 2009 
Cantel Medical Corp. Reports Operating Results (10-Q) Jun 08 2009 
Cantel Medical Corp. Reports Operating Results (10-Q) Mar 12 2009 

More From Other Websites
Cantel Medical Corp. To Hold Conference Call To Discuss Results For Its Fourth Quarter And Fiscal... Sep 22 2014
Cantel Medical Subsidiary - MEDIVATORS ENDOCUFF™ Overtube Improves Adenoma and Polyp Detection Sep 10 2014
Christopher Clark, the CFO of Neovasc Inc. (NVCN), Interviews with The Wall Street Transcript Aug 01 2014
Cantel Medical Completes Acquisition Of PuriCore International Ltd. Jul 01 2014
Medivators Launches JET PREP™ Device to Improve Polyp Detection Jun 23 2014
Cantel Medical Board Of Directors Authorizes Regular Semiannual Dividend Jun 19 2014
CANTEL MEDICAL CORP Financials Jun 17 2014
CANTEL MEDICAL CORP Files SEC form 10-Q, Quarterly Report Jun 09 2014
CANTEL MEDICAL CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Jun 05 2014
Cantel Medical Corp. to Host Third Quarter Earnings Webcast Live on Thursday, June 5, 2014 Jun 05 2014
Cantel Medical Reports Operating Income Growth Of 18% On A 14% Sales Increase For Third Quarter... Jun 05 2014
Cantel Medical agrees to acquire PuriCore International for $26.9M Jun 04 2014
Cantel Medical Enters Into Definitive Agreement To Acquire PuriCore International Ltd. Jun 04 2014
Cantel Medical Corp. To Hold Conference Call To Discuss Results For Its Third Quarter Ended April... May 30 2014
Cantel Medical, OsteoSymbionics announce FDA 510(k) clearance of ClearShield May 28 2014
Cantel Medical and OsteoSymbionics Announce FDA 510(k) Clearance of ClearShield™ Implant Using... May 28 2014
Cantel Medical To Present At The Jefferies 2014 Global Healthcare Conference May 19 2014
CANTEL MEDICAL CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Apr 17 2014
Cantel Medical announces retirement of CFO Sheldon Apr 16 2014
Cantel Medical Announces Retirement Of Chief Financial Officer And Transition Process Apr 16 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK